Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q10 formulations

International Journal of Pharmaceutics

Volumn 363, Issue 1-2, 2008, Pages 112-117

  Hatanaka, Junya ^a,b   Kimura, Yoshihiro ^b   Lai Fu, Zhogn ^c   Onoue, Satomi ^a   Yamada, Shizuo ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Yokohama Oils and Fats Industry Corporation   (Japan)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Coenzyme Q10; DSC; Emulsion; PXRD

Indexed keywords

CYCLODEXTRIN; GLYCEROL; GUM ARABIC; MEDIUM CHAIN TRIACYLGLYCEROL; NANOPARTICLE; PHOSPHATIDYLCHOLINE; SUGAR ALCOHOL; SURFACTANT; UBIDECARENONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; EMULSION; LIGHT SCATTERING; MALE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; X RAY POWDER DIFFRACTION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; CYCLODEXTRINS; EMULSIONS; LIGHT; MALE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDER DIFFRACTION; POWDERS; RATS; RATS, SPRAGUE-DAWLEY; SCATTERING, RADIATION; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; UBIQUINONE; WATER;

EID: 51849164427     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.07.019     Document Type: Article

References (41)

1. Ahmed I.S., and Aboul-Einien M.H. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin. Eur. J. Pharm. Sci. 32 (2007) 58-68
2. Badmaev V., Majeed M., and Prakash L. Piperine derived from black pepper increases the plasma levels of coenzyme Q10 following oral supplementation. J. Nutr. Biochem. 11 (2000) 109-113
3. Bhagavan H.N., and Chopra R.K. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res. 40 (2006) 445-453
4. 10 binary solid dispersions for enhanced solubility and dissolution. Biol. Pharm. Bull. 30 (2007) 1171-1176
5. Boon C.S., Xu Z., Yue X., McClements D.J., Weiss J., and Decker E.A. Factors affecting lycopene oxidation in oil-in-water emulsions. J. Agric. Food Chem. 56 (2008) 1408-1414
6. Bunjes H., Drechsler M., Koch M.H., and Westesen K. Incorporation of the model drug ubidecarenone into solid lipid nanoparticles. Pharm. Res. 18 (2001) 287-293
7. 10 formulations in human subjects. Int. J. Vitam. Nutr. Res. 68 (1998) 109-113
8. Dollo G., Le Corre P., Guerin A., Chevanne F., Burgot J.L., and Leverge R. Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur. J. Pharm. Sci. 19 (2003) 273-280
9. Ghosh P.K., and Murthy R.S. Microemulsions: a potential drug delivery system. Curr. Drug. Deliv. 3 (2006) 167-180
10. Gursoy R.N., and Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004) 173-182
11. Jang D.J., Jeong E.J., Lee H.M., Kim B.C., Lim S.J., and Kim C.K. Improvement of bioavailability and photostability of amlodipine using redispersible dry emulsion. Eur. J. Pharm. Sci. 28 (2006) 405-411
12. 10 preparations in humans. Int. J. Clin. Pharmacol. Ther. 41 (2003) 42-48
13. Khandavilli S., and Panchagnula R. Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. J. Invest. Dermatol. 127 (2007) 154-162
14. 10 intravenously administered in an emulsion to rats: emulsifying agents and lipoprotein lipase activity. J. Pharm. Pharmacol. 38 (1986) 659-662
15. Kojima T., Onoue S., Katoh F., Teraoka R., Matsuda Y., Kitagawa S., and Tsuhako M. Effect of spectroscopic properties on photostability of tamoxifen citrate polymorphs. Int. J. Pharm. 336 (2007) 346-351
16. 10 in beagle dogs. Chem. Pharm. Bull. (Tokyo) 47 (1999) 1024-1028
17. 10: formulation development and bioavailability assessment. Int. J. Pharm. 212 (2001) 233-246
18. Matsuda Y., and Masahara R. Photostability of solid-state ubidecarenone at ordinary and elevated temperatures under exaggerated UV irradiation. J. Pharm. Sci. 72 (1983) 1198-1203
19. McClements D.J., Decker E.A., and Weiss J. Emulsion-based delivery systems for lipophilic bioactive components. J. Food Sci. 72 (2007) R109-R124
20. Melander A. Influence of food on the bioavailability of drugs. Clin. Pharmacokinet. 3 (1978) 337-351
21. Mosqueira V.C., Legrand P., Pinto-Alphandary H., Puisieux F., and Barratt G. Poly(d,l-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. J. Pharm. Sci. 89 (2000) 614-626
22. 10-Eudragit solid dispersion. Drug Dev. Ind. Pharm. 28 (2002) 49-57
23. Onoue S., Igarashi N., Yamauchi Y., Murase N., Zhou Y., Kojima T., Yamada S., and Tsuda Y. In vitro phototoxicity of dihydropyridine derivatives: a photochemical and photobiological study. Eur. J. Pharm. Sci. 33 (2008) 262-270
24. 10 self-emulsifying drug delivery systems (SEDDS). Int. J. Pharm. 273 (2004) 63-73
25. Pouton C.W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29 (2006) 278-287
26. Raffin Pohlmann A., Weiss V., Mertins O., Pesce da Silveira N., and Staniscuaski Guterres S. Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: development, stability evaluation and nanostructure models. Eur. J. Pharm. Sci. 16 (2002) 305-312
27. Ratnam D.V., Ankola D.D., Bhardwaj V., Sahana D.K., and Kumar M.N. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J. Control Release 113 (2006) 189-207
28. Sarker D.K. Engineering of nanoemulsions for drug delivery. Curr. Drug. Deliv. 2 (2005) 297-310
29. Shafiq S., Shakeel F., Talegaonkar S., Ahmad F.J., Khar R.K., and Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 66 (2007) 227-243
30. 10 nanoparticles. Pharm. Res. 12 (1995) 201-208
31. Singh K.K., and Vingkar S.K. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. Int. J. Pharm. 347 (2008) 136-143
32. Singhal D., and Curatolo W. Drug polymorphism and dosage form design: a practical perspective. Adv. Drug Deliv. Rev. 56 (2004) 335-347
33. Takeuchi H., Sasaki H., Niwa T., Hino T., Kawashima Y., Uesugi K., and Ozawa H. Redispersible dry emulsion system as novel oral dosage form of oily drugs: in vivo studies in beagle dogs. Chem. Pharm. Bull. (Tokyo) 39 (1991) 3362-3364
34. 10 by complexation with gamma-cyclodextrin in healthy adults. Nutr. Res. 26 (2006) 503-508
35. Turunen M., Appelkvist E.L., Sindelar P., and Dallner G. Blood concentration of coenzyme Q(10) increases in rats when esterified forms are administered. J. Nutr. 129 (1999) 2113-2118
36. 10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorB. J. Med. Food 8 (2005) 397-399
37. 10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction. Pharm. Res. 24 (2007) 2131-2137
38. Vyas T.K., Shahiwala A., and Amiji M.M. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int. J. Pharm. 347 (2008) 93-101
39. Xia S., Xu S., and Zhang X. Optimization in the preparation of coenzyme Q10 nanoliposomes. J. Agric. Food Chem. 54 (2006) 6358-6366
40. Xia S., Xu S., Zhang X., and Zhong F. Effect of coenzyme Q(10) incorporation on the characteristics of nanoliposomes. J. Phys. Chem. B 111 (2007) 2200-2207
41. 10 with beta-cyclodextrin studied by polarography. Yao Xue Xue Bao 41 (2006) 671-674